MEG3 and neoplasm: Notably, Meg3 deficiency dramatically attenuated tumor growth in ApcminmiR-708−/− mice, hinting that the combined application of agomirs of Meg3 and antagomirs of miR-708 might contribute to therapy of CRC in the clinic.